Savinin

Catalog No. :
ACKBIF758
CAS No. :
493-95-8
Molecular Formula :
C20H16O6
Molecular Weight :
352.34

IUPAC Name:(R,E)-4-(benzo[d][1,3]dioxol-5-ylmethyl)-3-(benzo[d][1,3]dioxol-5-ylmethylene)dihydrofuran-2(3H)-one

Savinin structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$716.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSavinin
IUPAC Name(R,E)-4-(benzo[d][1,3]dioxol-5-ylmethyl)-3-(benzo[d][1,3]dioxol-5-ylmethylene)dihydrofuran-2(3H)-one
Molecular FormulaC20H16O6
Molecular Weight352.34
SMILESO=C1OC[C@H](CC2=CC=C(OCO3)C3=C2)/C1=C\C4=CC=C(OCO5)C5=C4
InChI KeyCMJGAYUQSLJSCR-ULIPXBITSA-N
Synonymsavinin;(-)-Hibalactone;(4R)-4,5-Dihydro-4-(1,3-benzodioxole-5-ylmethyl)-3-[(E)-1,3-benzodioxol-5-ylmethylene]furan-2(3H)-one;(R)-4,5-Dihydro-4-(1,3-benzodioxol-5-ylmethyl)-3-[(E)-1,3-benzodioxol-5-ylmethylene]furan-2(3H)-one;Hibalactone;2(3H)-Furanone, 4-(1,3-benzodioxol-5-ylmethyl)-3-(1,3-benzodioxol-5-ylmethylene)dihydro-, (3E,4R)-;(3E,4R)-4-(1,3-benzodioxol-5-ylmethyl)-3-(1,3-benzodioxol-5-ylmethylidene)oxolan-2-one;AI 3-26464
CAS No.493-95-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACKBIF758 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKBIF758 route product structure diagram
    ACKBIF758493-95-8
Inquiry

2. ACKBIF758 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKBIF758 route product structure diagram
    ACKBIF758493-95-8
Inquiry

Comments (0)